Related references
Note: Only part of the references are listed.Preclinical evaluation and reverse phase protein Array-based profiling of PI3K and MEK inhibitors in endometrial carcinoma in vitro
Ozlem Aslan et al.
BMC CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study
Dejan Juric et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Endometrial cancer cells exhibit high expression of p110β and its selective inhibition induces variable responses on PI3K signaling, cell survival and proliferation
Thomas Karlsson et al.
ONCOTARGET (2017)
Distinct molecular landscapes between endometrioid and nonendometrioid uterine carcinomas
Nathaniel L. Jones et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α
Lauren M. Thorpe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer Cells
Jing Zhang et al.
CELL REPORTS (2017)
PIK3CA exon9 mutations associate with reduced survival, and are highly concordant between matching primary tumors and metastases in endometrial cancer
Siv Mjos et al.
SCIENTIFIC REPORTS (2017)
Functional characterization of a novel somatic oncogenic mutation of PIK3CB
Andrew D. Whale et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors
Joaquin Mateo et al.
CLINICAL CANCER RESEARCH (2017)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group
P-E Heudel et al.
BRITISH JOURNAL OF CANCER (2017)
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancers
Q. Wang et al.
ONCOGENE (2016)
Oncogenic activation of the PI3-kinase p110β isoform via the tumor-derived PIK3CβD1067V kinase domain mutation
E. Pazarentzos et al.
ONCOGENE (2016)
A polybasic motif in ErbB3-binding protein 1 (EBP1) has key functions in nucleolar localization and polyphosphoinositide interaction
Thomas Karlsson et al.
BIOCHEMICAL JOURNAL (2016)
The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34
Jonathan M. Backer
BIOCHEMICAL JOURNAL (2016)
Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways
Phillip T. Hawkins et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
GPCR Signaling Mediates Tumor Metastasis via PI3Kβ
Bassem D. Khalil et al.
CANCER RESEARCH (2016)
Activating Mutations in PIK3CB Confer Resistance to PI3K Inhibition and Define a Novel Oncogenic Role for p110β
Yoshito Nakanishi et al.
CANCER RESEARCH (2016)
p110 and p110 isoforms of PI3K signaling: are they two sides of the same coin?
Paramjeet Singh et al.
FEBS LETTERS (2016)
The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis
William J. Gibson et al.
NATURE GENETICS (2016)
New Targeted Agents in Endometrial Cancer: Are We Really Making Progress?
Victor Rodriguez-Freixinos et al.
CURRENT ONCOLOGY REPORTS (2016)
Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles
Eejung Kim et al.
CANCER DISCOVERY (2016)
Measurement of PIP3 Levels Reveals an Unexpected Role for p110β in Early Adaptive Responses to p110α-Specific Inhibitors in Luminal Breast Cancer
Carlotta Costa et al.
CANCER CELL (2015)
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
Ursula Matulonis et al.
GYNECOLOGIC ONCOLOGY (2015)
Synergy in activating class I PI3Ks
John E. Burke et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
A PI3K p110β-Rac signalling loop mediates Pten-loss-induced perturbation of haematopoiesis and leukaemogenesis
Haluk Yuzugullu et al.
NATURE COMMUNICATIONS (2015)
PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex
Pengda Liu et al.
CANCER DISCOVERY (2015)
Novel Role for p110β PI 3-Kinase in Male Fertility through Regulation of Androgen Receptor Activity in Sertoli Cells
Julie Guillermet-Guibert et al.
PLOS GENETICS (2015)
Convergent loss of PTEN leads to clinical resistance to a PI(3)Kα inhibitor
Dejan Juric et al.
NATURE (2015)
Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients
Anna Berg et al.
ONCOTARGET (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
The Emerging Genomic Landscape of Endometrial Cancer
Matthieu Le Gallo et al.
CLINICAL CHEMISTRY (2014)
Classes of phosphoinositide 3-kinases at a glance
Steve Jean et al.
JOURNAL OF CELL SCIENCE (2014)
Classification of endometrial carcinoma: more than two types
Rajmohan Murali et al.
LANCET ONCOLOGY (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
Ralph Fritsch et al.
CELL (2013)
New Strategies in Endometrial Cancer: Targeting the PI3K/mTOR Pathway-The Devil Is in the Details
Andrea P. Myers
CLINICAL CANCER RESEARCH (2013)
PI3K Pathway Dependencies in Endometrioid Endometrial Cancer Cell Lines
Britta Weigelt et al.
CLINICAL CANCER RESEARCH (2013)
Integrated genomic characterization of endometrial carcinoma
Gad Getz et al.
NATURE (2013)
Characterization of a Tumor-Associated Activating Mutation of the p110β PI 3-Kinase
Hashem A. Dbouk et al.
PLOS ONE (2013)
Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs)
Oscar Vadas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
Inma M. Berenjeno et al.
BIOCHEMICAL JOURNAL (2012)
Identification of Molecular Pathway Aberrations in Uterine Serous Carcinoma by Genome-wide Analyses
Elisabetta Kuhn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Markers for individualised therapy in endometrial carcinoma
Helga B. Salvesen et al.
LANCET ONCOLOGY (2012)
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
Matthieu Le Gallo et al.
NATURE GENETICS (2012)
PI3K signalling: the path to discovery and understanding
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA)
John E. Burke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CELL BIOLOGY G Protein-Coupled Receptor-Mediated Activation of p110β by Gβγ Is Required for Cellular Transformation and Invasiveness
Hashem A. Dbouk et al.
SCIENCE SIGNALING (2012)
Functional Characterization of an Isoform-Selective Inhibitor of PI3K-p110β as a Potential Anticancer Agent
Jing Ni et al.
CANCER DISCOVERY (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Unique Spectrum of Somatic PIK3CA (p110α) Mutations Within Primary Endometrial Carcinomas
Meghan L. Rudd et al.
CLINICAL CANCER RESEARCH (2011)
PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors
Bozena Konopka et al.
HUMAN PATHOLOGY (2011)
Nuclear but Not Cytosolic Phosphoinositide 3-Kinase Beta Has an Essential Function in Cell Survival
Amit Kumar et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
Structure of Lipid Kinase p110β/p85β Elucidates an Unusual SH2-Domain-Mediated Inhibitory Mechanism
Xuxiao Zhang et al.
MOLECULAR CELL (2011)
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2011)
High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability
Lydia W. T. Cheung et al.
CANCER DISCOVERY (2011)
The emerging mechanisms of isoform-specific PI3K signalling
Bart Vanhaesebroeck et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
A biochemical mechanism for the oncogenic potential of the p110β catalytic subunit of phosphoinositide 3-kinase
Hashem A. Dbouk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cancer-derived mutations in the regulatory subunit p85α of phosphoinositide 3-kinase function through the catalytic subunit p110α
Minghao Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Nuclear phosphoinositide 3-kinase β controls double-strand break DNA repair
Amit Kumar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PIKing the right isoform: the emergent role of the p110β subunit in breast cancer
Silvia Carvalho et al.
VIRCHOWS ARCHIV (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Somatic Mutations in p85α Promote Tumorigenesis through Class IA PI3K Activation
Bijay S. Jaiswal et al.
CANCER CELL (2009)
Update of the LIPID MAPS comprehensive classification system for lipids
Eoin Fahy et al.
JOURNAL OF LIPID RESEARCH (2009)
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
H. B. Salvesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Specific function of phosphoinositide 3-kinase beta in the control of DNA replication
Miriam Marques et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A frequent kinase domain mutation that changes the interaction between PI3Kα and the membrane
Diana Mandelker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mammalian phosphoinositide kinases and phosphatases
Takehiko Sasaki et al.
PROGRESS IN LIPID RESEARCH (2009)
Regulation of phosphoinositide 3-kinase expression in health and disease
Klaartje Kok et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
PIK3CA gene mutations and amplifications in uterine cancers, identified by methods that avoid confounding by PIK3CA pseudogene sequences
Takahito Miyake et al.
CANCER LETTERS (2008)
Phosphoinositide 3-kinases p110α and p110β regulate cell cycle entry, exhibiting distinct activation kinetics in G1 Phase
Miriam Marques et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Comprehensive identification of PIP3-regulated PH domains from C elegans to H sapiens by model prediction and live imaging
Wei Sun Park et al.
MOLECULAR CELL (2008)
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration
Mariona Graupera et al.
NATURE (2008)
Essential roles of PI(3)K-p110β in cell growth, metabolism and tumorigenesis
Shidong Jia et al.
NATURE (2008)
The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ
Julie Guillermet-Guibert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
PTEN-deficient cancers depend on PIK3CB
Susan Wee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Phosphoinositide 3-Kinase p110β Activity: Key Role in Metabolism and Mammary Gland Cancer but Not Development
Elisa Ciraolo et al.
SCIENCE SIGNALING (2008)
The structure of a human p110α/p85α complex elucidates the effects of oncogenic PI3Kα mutations
Chuan-Hsiang Huang et al.
SCIENCE (2007)
Targeted RNA interference of phosphatidylinositol 3-kinase p110-β induces apoptosis and proliferation arrest in endometrial carcinoma cells
H. J. An et al.
JOURNAL OF PATHOLOGY (2007)
Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers
Barbara Geering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
LMSD: LIPID MAPS structure database
Manish Sud et al.
NUCLEIC ACIDS RESEARCH (2007)
PIKK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia
Monica Prasad Hayes et al.
CLINICAL CANCER RESEARCH (2006)
Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation
LC Foukas et al.
NATURE (2006)
Oncogenic transformation induced by the p110β, -γ, and -δ isoforms of class I phosphoinositide 3-kinase
S Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma
K Oda et al.
CANCER RESEARCH (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
The p85 regulatory subunit controls sequential activation of phosphoinositide 3-kinase by Tyr kinases and Ras
C Jiménez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A specific function for phosphatidylinositol 3-kinase α (p85α-p110α) in cell survival and for phosphatidylinositol 3-kinase β (p85α-p110β) in de novo DNA synthesis of human colon carcinoma cells
C Bénistant et al.
ONCOGENE (2000)
Structural basis of 3-phosphoinositide recognition by pleckstrin homology domains
SE Lietzke et al.
MOLECULAR CELL (2000)
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers
GL Mutter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
